Adverse Events and Device Failures Associated with Pancreatic Stents: A Comprehensive Analysis Using the FDA’s MAUDE Database

Jaber F., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Alsakarneh S., Department of Medicine, University of Missouri-Kansas City, Kansas City, MO, United States; Alsharaeh T., Department of Medical Education, Faculty of Medicine, The University of Jordan, Amman, Jordan; Salahat A.-J., Department of Medical Education, Faculty of Medicine, The University of Jordan, Amman, Jordan; Jaber M., Department of Medical Education, Faculty of Medicine, Al-Azhar University, Gaza, Palestine; Abboud Y., Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States; Aldiabat M., Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, United States, Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States; Ahmed K., Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States; Abdallah M., Division of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, United States; Abdel-Jalil A., Division of Gastroenterology and Hepatology, MetroHealth Medical Center, Cleveland, OH, United States; Bilal M., Division of Gastroenterology and Hepatology, University of Minnesota Medical Center, Minneapolis, MN, United States, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States; Barakat M., Division of Gastroenterology, Stanford University, Stanford, CA, United States; Adler D.G., Center for Advanced Therapeutic Endoscopy, Porter Adventist Hospital, Centura Health, Denver, CO, United States